Boston Scientific
470 hedge funds and large institutions have $21.5B invested in Boston Scientific in 2015 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 153 increasing their positions, 180 reducing their positions, and 43 closing their positions.
50% more call options, than puts
Call options by funds: $38.7M | Put options by funds: $25.8M
14% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 43
0.86% more ownership
Funds ownership: 89.85% → 90.71% (+0.86%)
1% more capital invested
Capital invested by funds: $21.3B → $21.5B (+$135M)
0% more funds holding
Funds holding: 470 → 470 (0)
15% less repeat investments, than reductions
Existing positions increased: 153 | Existing positions reduced: 180
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$312M |
| 2 |
AIM
abrdn Investment Management
Edinburgh,
United Kingdom
|
+$192M |
| 3 |
O
OrbiMed
New York
|
+$146M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$140M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$136M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$243M |
| 2 |
JP Morgan Chase
New York
|
-$173M |
| 3 |
SO
STRS Ohio
Columbus,
Ohio
|
-$85M |
| 4 |
NTC
North Tide Capital
Boston,
Massachusetts
|
-$79.9M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$60.5M |
BSX Hedge Fund Activity: Q2 2015 in Review
470 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2015, worth a combined $21.5B — up 0.63% from $21.3B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new BSX positions and 43 closed out — a net gain of 6 holders — while 153 added to existing stakes and 180 trimmed.
The largest buyer was Winslow Capital Management, opening a new position worth an estimated $312M. The largest seller was Vanguard Group, cutting an estimated $243M.
- 470 institutional investors held Boston Scientific (BSX) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $21.5B of Boston Scientific stock for Q2 2015, up 0.63% quarter-over-quarter.
- 49 funds opened new Boston Scientific positions in Q2 2015 and 43 closed out, a net change of +6 holders.
- The largest Boston Scientific buyer in Q2 2015 was Winslow Capital Management, an estimated $312M added.
- The largest Boston Scientific seller in Q2 2015 was Vanguard Group, an estimated $243M sold.
Based on aggregated 13F filings for Q2 2015.